Story preview
Continue reading on the publisher site for the full article.
Read on publisher →Yahoo Finance
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee
Coverage
Tone
Outlets covering it
7
in the last 3 days
First reported
2 days ago
5 outlets since
Countries
6 other outlets reported this story in the last 3 days.
Thermo Fisher Scientific (TMO) is back in focus after Quantum BioPharma selected its clinical research arm to run a Phase 2 multiple sclerosis trial, highlighting growing reliance on the company’s end to end drug development services. Thermo Fisher Scientific’s recent contract wins and product launches come against a…
Thermo Fisher Scientific has delivered a solid share price run in recent years, which puts a spotlight on whether the current US$662.24 level lines up with the cash it can generate over time. With fresh partnerships and industry collaborations in play, the key consideration is how much of that future cash flow story…
Thermo Fisher Scientific stock is at EUR 592.70 pre-market at Lang & Schwarz. The company is schedul